EUVIMEDEUVIMED entdecken
Crossref

Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2

Yaping Niu, Jinhuan Ou, Xiaoru Zhong, Piao Luo, Junhui Chen, Ashok Iyaswamy, Haibo Tong, Zhou Zhu, Peng Chen, Xu Wei, Wei Zhang, Hualin Ma und 3 weitere

Advanced Biology · 2025

DOI: 10.1002/adbi.202500031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Yaping Niu und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of…. Hauptthemen laut MEDLINE: Peroxiredoxins, Reactive Oxygen Species, Autophagy, Kidney Neoplasms. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Shenzhen key Laboratory of Kidney Diseases, China Postdoctoral Science Foundation, Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucocalyxin A (GLA), a bioactive diterpenoid from the medicinal plant Rabdosia japonica , demonstrates potent antitumor activity, yet its molecular mechanisms in renal cell carcinoma (RCC) remain elusive. Here, GLA is reported to trigger cytotoxicity in RCC cells through reactive oxygen species (ROS) overaccumulation. Mechanistically, ROS surge activates autophagy, and pharmacological or genetic autophagy inhibition significantly rescues GLA‐induced cell death, indicating autophagy acts as a pro‐death effector in this context. Employing activity‐based protein profiling (ABPP) coupled with proteomic analysis, peroxiredoxins PRDX1/2 are identified as direct covalent targets of GLA. Functional validation reveals that PRDX1/2 overexpression mitigates GLA‐mediated apoptosis, establishing their role as critical redox sensors governing cell fate. The findings delineate a ROS‐autophagy‐apoptosis axis driven by PRDX1/2 targeting, positioning GLA as a novel therapeutic scaffold for RCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxiredoxinsReactive Oxygen SpeciesAutophagyKidney NeoplasmsDiterpenes, KauraneCarcinoma, Renal CellHumansCell Line, TumorApoptosisAntioxidants

Stichwörter der Autor:innen

GLAapoptosisautophagyperoxiredoxinrenal carcinoma

Substanzen

PeroxiredoxinsReactive Oxygen Speciesglaucocalyxin APRDX1 protein, humanPRDX2 protein, humanDiterpenes, KauraneAntioxidants

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
  • Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, 518020, Ch…
  • School of Traditional Chinese Medicine and School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, 641021, India.
  • Experimental Research Center, China Academy of Traditional Chinese Medicine, Beijing, 100700, China.

ORCID-Profile: Chuanbin Yang

Förderung

  • Shenzhen key Laboratory of Kidney Diseases
  • China Postdoctoral Science Foundation
  • Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties
  • Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences
  • Shenzhen Science and Technology Program
  • Shenzhen Medical Academy of Research and Translation
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Niu, Y., Ou, J., Zhong, X., Luo, P., Chen, J., Iyaswamy, A., Tong, H., Zhu, Z., Chen, P., Wei, X., Zhang, W., Ma, H., Feng, Y., Yang, C., & Wang, J. (2025). Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2. Advanced Biology. https://doi.org/10.1002/adbi.202500031

Vancouver

Niu Y, Ou J, Zhong X, Luo P, Chen J, Iyaswamy A, et al. Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2. Advanced Biology. 2025. doi:10.1002/adbi.202500031

BibTeX
@article{Niu2025,
  author = {Niu, Yaping and Ou, Jinhuan and Zhong, Xiaoru and Luo, Piao and Chen, Junhui and Iyaswamy, Ashok and Tong, Haibo and Zhu, Zhou and Chen, Peng and Wei, Xu and Zhang, Wei and Ma, Hualin and Feng, Yulin and Yang, Chuanbin and Wang, Jigang},
  title = {Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2},
  journal = {Advanced Biology},
  year = {2025},
  doi = {10.1002/adbi.202500031}
}
Kostenlos starten →